CDH6

(redirected from CAD6)

CDH6

A gene on chromosome 5p13.3 that encodes a calcium-dependent cell–cell adhesion glycoprotein (cadherin), which is involved in regulating cell–cell adhesions, mobility and proliferation of epithelial cells. CDH6 is a so-called type-II (atypical) cadherin—which lacks a HAV cell adhesion recognition sequence specific to type-I cadherins—and may play a role in kidney, endometrial and placenta development. It is highly expressed in the brain, cerebellum and kidneys.

Molecular pathology
Decreased CDH6 expression is linked to tumour growth and metastasis.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
References in periodicals archive ?
To date, Tevosol has raised CAD6.3m in seed financing and will next seek venture funding to support manufacturing, clinical investigation and commercial launch.
(SH:601899, SEHK:2899) have announced that in response to Zijin's offer to purchase all of the issued and outstanding common shares of Nevsun for CAD6.00 per share, an additional 9,526,987 Nevsun Shares, representing approximately 3.07 percent of all issued and outstanding Nevsun Shares, have been deposited under the Offer and not withdrawn during the extension period.
The company also said on 5 September it plans an all-cash takeover of Canadian-listed mining company, Nevsun Resources Ltd (Nevsun), at CAD6 per share for around 302 million shares, or a total of CAD1.84 billion (USD1.4 billion).
(CSE: IAN)(CSE: IAN.CN) (OTC: ITHUF), which owns, operates, and partners with licensed cannabis operations throughout the United States, has said that it has, as of December 7, 2018, granted 1,367,500 incentive stock options, exercisable at CAD6.00 per stock option to advisory board members, consultants, and employees of the company.
The prevalence of CAD in chronic conduction disorder has been reported to be 30-70%, depending on patients characteristics and the ways to detect CAD6.
It was reached after several days of intense bargaining and, if ratified by workers, includes a CAD325m investment in Brampton for a new paint shop and CAD6.4m to upgrade the automaker's casting plant in Ebitocoke, Ontario.
SunOpta Grows in Canada: In August 2015, Canadian natural health products company SunOpta entered a deal to buy Niagara Natural Fruit Snack for around CAD6.7mn (USD5.1mn).
Reportedly, the AP&C division generated CAD6.5m of revenues during 2013 with an EBITDA result of about CAD1.5m, and is expected to have a positive effect on Arcam's earnings per share in 2014.
The addition of the particular business, which booked revenues of CAD6.5m and EBITDA of some CAD1.5m in 2013, is projected to boost the buyer's earnings per share this year.
For the third quarter 2012, revenues were CAD7.2m, compared to CAD6.67m in the same quarter in fiscal 2011.
The company reported total sales of CAD6.1m for the year ended 30 September 2011, or a 15% decline over the prior fiscal year.
Intellectual property management company MOSAID Technologies Incorporated (TSX:MSD) reported on Wednesday a net loss of CAD4.9m for its second quarter of fiscal 2012, compared with net income of CAD6.3m in the same quarter last year.